- Dr. Andy Potter among Saskatchewan Order of Merit recipients
Dr. Potter is one of six people to receive the province's highest honour this year.
- Reverse vaccinology approach for novel bovine tuberculosis vaccines: The Canadian ReVAMP project
Researchers are taking a reverse vaccinology approach to develop new vaccines against bTB. Read more in the OiE Panorama, Controlling bovine tuberculosis: a One Health challenge
- Efforts to Create ASF Vaccines Result in Cautious Optimism
VIDO-InterVac scientists, in partnership with the Canadian Food Inspection Agency and partners in Kenya where African Swine Fever is present in pigs, have been working to develop vaccines to protect against the virus.
- Government of Canada invests in top research labs
VIDO-InterVac receives additional support from the Canadian Foundation for Innovation's Major Science Initiatives Fund.
- Dr. Andrew Potter receives 2019 Saskatchewan Order of Merit
Dr. Andrew Potter, VIDO-InterVac's former Director and CEO, is one of this year's recipients of the Saskatchewan Order of Merit.
- Lung plague vaccine wins international award
A vaccine against contagious bovine pleuropneumonia (CBPP) won the award for Best Veterinary Vaccine at the 12th World Vaccine Congress in Washington DC.
- Agencies search for ASF vaccine
VIDO-InterVac is helping lead the way developing a vaccine for African swine fever. In May, more than 30 different vaccine candidates for the disease are scheduled for efficacy testing.
- Vaccine development speeding up
VIDO-InterVac in Saskatoon embraces new technology . Reverse vaccinology is a promising method for creating vaccines that in the near future will protect livestock from prevalent and chronic diseases.
- Using a new approach to create the first bovine tuberculosis vaccine
Bovine tuberculosis is a costly cattle disease that primarily affects low and middle-income countries. More than 50 million cattle are infected every year, costing an estimated US$3 billion annually.
- Six world-first vaccines among USask’s VIDO-InterVac contributions to global health
VIDO-InterVac has established itself as a leading global institute in protecting human and animal health since 1975, with six world-firsts among the eight vaccines it has commercialized.